Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis
| Autor: | Valeria Cammalleri, Marco Barbanti, Gian Paolo Ussia, Patrizia Aruta, Anna Maria Pistritto, Sebastiano Immè, Kunal Sarkar, Marilena Scarabelli, Corrado Tamburino, Massimiliano Mulè, Simona Gulino, Davide Capodanno |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
Cardiac Catheterization medicine.medical_specialty Time Factors Population Settore MED/11 - Malattie dell'Apparato Cardiovascolare Prosthesis Design Risk Assessment Severity of Illness Index TAVI Quality of life Risk Factors Surveys and Questionnaires Internal medicine Severity of illness Humans Medicine Prospective Studies Heart valve education Prospective cohort study Geriatric Assessment Aged Aged 80 and over Heart Valve Prosthesis Implantation Analysis of Variance education.field_of_study Chi-Square Distribution business.industry Age Factors aortic stenosis health Aortic Valve Stenosis Recovery of Function medicine.disease Stenosis Treatment Outcome medicine.anatomical_structure Italy quality-of-life Heart Valve Prosthesis Quality of Life Cardiology Population study Female Cardiology and Cardiovascular Medicine business Chi-squared distribution |
| Zdroj: | EuroIntervention. 7:573-579 |
| ISSN: | 1774-024X |
| DOI: | 10.4244/eijv7i5a93 |
| Popis: | AIMS Transcatheter aortic valve implantation (TAVI) is an emerging alternative to medical therapy reserved to a limited population with severe aortic stenosis. Quality-of-life (QoL) is a critical measure of effectiveness of TAVI in this patient population. In this prospective study, we sought to assess one year changes in QoL in patients who underwent TAVI. METHODS AND RESULTS From June 2007 to July 2010, 149 consecutive patients underwent TAVI using the 18 Fr CoreValve (Medtronic Inc, Minneapolis, MN, USA) or the Edwards SAPIEN XT heart valve (Edwards Lifescience, Irvine, CA, USA) at our institution. Of these, 143 patients with successful prosthesis implantation comprised the study population. The SF-12v2 Health-Survey questionnaire provides scales for physical (physical component summary [PCS]) and mental (mental component summary [MCS]) health. Among patients included in the present analysis, device success was obtained in 138 patients (96.5%). Mean preprocedural SF-12v2 scores showed an important upgrading after TAVI: PCS improved from 28.3 to 44.0 at five months and 42.4 at 12 months (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|